Xu Han

机构：University of Science and Technology of China, Centre National de la Recherche Scientifique, Heilongjiang University of Science and Technology, Université Toulouse III - Paul Sabatier, Qingdao Agricultural University, Shenyang University of Technology, Hefei University of Technology, Northwestern Polytechnical University, Université Fédérale de Toulouse Midi-Pyrénées, Hebei University of Technology, Chinese Academy of Sciences, Institut National Polytechnique de Toulouse, Hebei University of Science and Technology, Laboratoire de Génie Chimique, Changchun Institute of Applied Chemistry, State Key Laboratory of Hydrology-Water Resources and Hydraulic Engineering, Center for Agricultural Resources Research, Second Affiliated Hospital of Jilin University, Laboratoire de Microbiologie et Génétique Moléculaires, Hebei Petroleum University of Technology, Centre de Biologie Intégrative de Toulouse, Nanchang Hangkong University, Northwestern Polytechnic University · ORCID：0000-0002-8967-4372

发表论文 854 篇 · 总被引 19656 次 · h-index 77

代表论文

Lanthanum-Induced Quasi-Covalent Bonding and Chemical Potential Bridging in Pt 3 Co Intermetallic Catalysts for Durable Fuel Cells (2026 · Journal of the American Chemical Society · 被引 11)
A two-stage data-driven approach for remaining useful life prediction (2026 · Acta Mechanica Sinica · 被引 2)
Genome-wide characterization of BPC transcription factors in pear and functional validation of PbBPC5 in drought tolerance regulation (2026 · Frontiers in Plant Science · 被引 2)
Fabrication of multifunctional PVA mulch films reinforced by hydrothermally treated corncob lignocellulose for facilitating crop growth (2026 · International Journal of Biological Macromolecules · 被引 1)
Development of a cancer metastasis-associated risk model via multi-machine-learning algorithms for prognostic risk evaluation and clinical application in oral squamous cell carcinoma (2025 · Journal of Translational Medicine · 被引 1)
Construction and validation of a disulfidptosis-related risk assessment model for prediction of prognosis, immune microenvironment, drug therapy, and microbiota in patients with low-grade glioma (2025 · International Journal of Surgery · 被引 1)